Chipped Pharmaceuticals from Production to in VIVO (in body) Drug Delivery Becoming Reality
暂无分享,去创建一个
Erick C. Jones | David J. Cochran | Joshua Bolton | Jamie Rogers | Shalini Gupta | Felicia Jefferson | Jae Bong Choi
[1] Alexander Zeier,et al. A Simulation of the Pharmaceutical Supply Chain to Provide Realistic Test Data , 2009, 2009 First International Conference on Advances in System Simulation.
[2] Sandra R. Stovall. Drug Pedigrees Are Here, but in What Form? , 2006 .
[3] Sweta Chakraborty,et al. Transparency Initiative by the FDA’s Center for Drug Evaluation and Research (CDER): Two qualitative studies of Public Perceptions , 2012, European Journal of Risk Regulation.
[4] David L. Laven. Introduction: Drug Diversion and Counterfeiting, Part II , 2006 .
[5] D. Miller. Food product traceability: new challenges, new solutions. , 2009 .
[6] Sanjay Jain,et al. Development of a high-level supply chain simulation model , 2001, Proceeding of the 2001 Winter Simulation Conference (Cat. No.01CH37304).
[7] Kate Traynor,et al. FDA seeks advice on track-and-trace systems. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[8] Susan F. Paparella. Drug shortages in the emergency department: managing a threat to patient safety. , 2012, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.
[9] Seongjin Park,et al. The Development of e-Pedigree Model for Securing Transparent Pharmaceutical Distribution Channel in Korea , 2012, ICHIT.
[10] Integrity of the pharmaceutical supply chain: product sourcing for patient safety. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[11] Julie Golembiewski. Drug shortages in the perioperative setting: causes, impact, and strategies. , 2012, Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses.